Tianyu shares: subsidiary Ebershatan tablets obtained a drug registration certificate
Time of Update: 2021-03-10
treatment for primary hypertension and type 2 diabetic nephropathy, which combines hypertension, was first developed and marketed by Sanofi Pharmaceuticals of France under the name Aprovel.
Hengrui lost its 200 billion-dollar market capitalization "share god" pit crying nearly 30,000 shareholders
Time of Update: 2021-03-05
approval from the State Drug Administration to issue the injection of Parecheb sodium "Drug Registration Approval", on December 19, its subsidiary Ruishi Biopharmaceutical Co., Ltd. submitted SHR030 to the FDA 2 clinical trial applications were accepted
Shangrong Healthcare's failed expansion lost its share price by 83.1 billion yuan, shrinking by 1.8 billion yuan
Time of Update: 2021-02-27
of medical device companies such as Purder Medical, Jinzhou Medical Equipment and so on. At present, the effect has not been achieved, the most expensive acquisition target Jinzhou medical performance did not meet expectations. expansion
Tian medicine shares: obtain the Serekib capsule drug registration certificate
Time of Update: 2021-01-14
On January 6, Tian Pharmaceutical Co., Ltd. announced that its subsidiary Tianjin Jinyao Pharmaceutical Co., Ltd. had recently received a "Drug Registration Certificate" on the specifications of 0.1g and 0.2g of Selesib capsules approved
Pfizer Lyrica lost 57% market share in three weeks after being blocked by nine generic drugs!
Time of Update: 2019-08-21
Although Pfizer has made the expectation that the sales of lycrica will decline after the generic drug goes on the market, at present, the reality seems to be worse than expected.
20 A-share listed animal husbandry and feed enterprises reported results, only 4 of them lost money
Time of Update: 2018-07-18
The main reasons are as follows: in the second quarter of 2018, the sales price of pig market rebounded less than expected, and the loss of the company's breeding sector is higher than previously expected; TBN 2.
Nash lost another point, galectin shares fell 30%
Time of Update: 2017-12-06
- China drug source December 6, 2017 [news event]: today, the Nash drug and galectin inhibitor gr-md-02 of galectin therapeutics, a biotechnology company, failed to reach the primary end point in a phase II clinic called nash-cx.
Behind Jiahe bio's a share: only one new three board plant extract concept share lost money
Time of Update: 2017-07-10
According to the statistical data of dig Beiwang, only one company in the new three board plant extract industry made a loss last year.
Another wave of inspections came and 31 pharmaceutical companies lost their GSP certificates
Time of Update: 2016-11-10
Recently, food and drug administrations around the world have issued various inspection results announcements, such as flight inspection, supervision and inspection, spot check
7 pharmaceutical companies lost GSP certificates, 5 were put on file for investigation
Time of Update: 2016-11-10
Recently, the food and Drug Administration of Liaoning, Anshan and Linyi province (city) issued successive announcements, withdrawing GSP certificates of three pharmaceutical enterprises, revoking four and putting five enterprises on file for investigation.
Three pharmaceutical companies lost their GSP certificates and 30 cancelled their production licenses
Time of Update: 2016-11-08
According to Article 23 of the measures for the supervision and administration of the production of medical devices (Order No. 7 of the State Food and Drug Administration), the Bureau will cancel their medical device manufacturing licenses according to law.
Something happened! 17 pharmaceutical companies lost certificates, 13 were ordered to rectify
Time of Update: 2016-10-19
Recently, the food and Drug Administration of Jinan, Changchun, Meishan, Guangxi, Guangzhou and other food and drug administrations announced that 12 pharmaceutical enterprises
12 pharmaceutical companies lost their certificates!
Time of Update: 2016-10-14
Today (October 14), the food and Drug Administration of Guangxi Zhuang Autonomous Region and the food and Drug Administration of Beijing withdrew / revoked the GSP certificates
Certificate lost, 48 Enterprises may not have a happy National Day holiday
Time of Update: 2016-10-08
Hubei food and Drug Administration revoked the "certificate of quality management specification for drug distribution" of Wuhan xinyingde Biological Products Co., Ltd. according to law, and took back the GSP certificates of the other seven pharmaceutical enterprises.
Ah, what a painful insight! 10 pharmaceutical companies lost their certificates!
Time of Update: 2016-09-07
It is reported that the food and Drug Administration of Shandong, Hubei, Fujian, etc
issued successive announcements, and a total of 8 pharmaceutical companies' GSP
Five pharmaceutical companies lost their certificates, and the rain in their hearts poured down
Time of Update: 2016-09-06
Recently, one pharmaceutical enterprise in Guangxi has been withdrawn GMP certificate; one pharmaceutical enterprise in Chongqing and Anhui has been withdrawn GSP certificate; one
18 pharmaceutical companies lost their certificates
Time of Update: 2016-08-31
On August 30, Linyi pharmaceutical regulatory bureau of Shandong Province issued two announcements, revoking 6 pharmaceutical companies and withdrawing the GSP certificates of 11
Week Jun: 59 pharmaceutical companies lost GMP / GSP certificate!
Time of Update: 2016-08-15
The 12th Five Year Plan for national drug safety puts forward five planning indicators for drug safety management: (1) all chemical and biological product standards meet
GSP certificates of another 10 pharmaceutical companies "lost"
Time of Update: 2016-08-04
According to Anhui and Shandong food and drug administration, the GSP certificates of 8 pharmaceutical enterprises were withdrawn, 4 in Anhui and 4 in Shandong respectively